To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators. The main policy domain is Government Operations, Criminal Justice, Trade.
Who Benefits and How
federal agencies and legislative administrators may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HC5B32DB7A15C42C691E69678125C6D39: 1. Short title This Act may be cited as the Stop Pills That Kill Act.
- Section HFE6FDAFCF5D24407A954ADAFDB704763: 2. Definition In this Act, the term counterfeit fentanyl or methamphetamine substance means a substance that— contains fentanyl, any analogue of fentanyl, or...
- Section HE261C5A6DA90442FB6C851DC9479167F: 3. Prohibited acts Section 403(d)(2) of the Controlled Substances Act (21 U.S.C. 843(d)(2)) is amended, in the matter preceding subparagraph (A), by inserting...
- Section H0328D24432E14D088FB1FA5ACFBF7041: 4. Comprehensive plan Not later than 180 days after the date of enactment of this Act, the Administrator of the Drug Enforcement Administration shall establish...
- Section H22664BC1318D443D8C854A97CDC4E0BA: 5. Report to Congress Not later than 1 year after the date of enactment of this Act, and every year thereafter, the Attorney General, in consultation with the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
This bill, To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators.
Key Policy Areas
Government Operations, Criminal Justice, Trade
Primary Purpose
This bill, To amend the Controlled Substances Act to prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators.
Policy Domains
Whole bill
Identified Gains
Contextual inference, no direct clause citation- federal agencies and legislative administrators
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- federal implementing agencies
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
IntroducedMr. Buck (for himself, Mr. Joyce of Ohio, Mr. Stanton, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_administrator"
- → The Administrator identified in the operative section
Key Definitions
Terms defined in this bill
a substance that— contains fentanyl, any analogue of fentanyl, or methamphetamine
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology